Viewing Study NCT05674656


Ignite Creation Date: 2025-12-24 @ 11:37 PM
Ignite Modification Date: 2025-12-25 @ 9:27 PM
Study NCT ID: NCT05674656
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2022-12-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Sponsor: ViiV Healthcare
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module